(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure. (2) Consists of inventory impairment and costs associated with the settlement of ...
First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren’s disease $75 million private placement strengthens balance sheet and supports ...
Andriy Blokhin has 5+ years of professional experience in public accounting, personal investing, and as a senior auditor with Ernst & Young. Thomas J. Brock is a CFA and CPA with more than 20 years of ...
Developing a marketing budget is important to ensure proper growth of your business. Your existing budget should be reviewed annually and adjusted depending on your prior year's sales and your goals ...
(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure. (2) Represents gain on sale of investment in BioClinica, Inc.
First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren's disease $75 million private placement strengthens balance sheet and supports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results